Menu
Enrolling by invitation NCT07592793

Community Gateway to Health Study

No phase Interventional Breast Cancer Screening Cervical Cancer Screening Colon Cancer Screening Tobacco Cessation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Tools and Training for Cancer Control, Enhancing Social Capital and Civic Engagement.
Who it may be relevant to
Registry conditions: Breast Cancer Screening, Cervical Cancer Screening, Colon Cancer Screening, Tobacco Cessation. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this study is to evaluate the impact of a multi-level intervention on cancer prevention and social determinants of health outcomes. This partnership between academic and community-based researchers aims to link community health centers and communities in ways that maximize both civic engagement and participation in cancer control care. The system-level intervention consists of two components: (1) provision of community health center systems-level tools for cancer screening (breast, cervical, colorectal) and tobacco cessation treatment gaps; and (2) digital access screening and navigation. These interventions will be delivered via usual care.

Interventions

  • Behavioral Tools and Training for Cancer Control
    This system level intervention consists of two components: (1) provision of community health center systems-level tools for cancer screening (breast, cervical, colorectal) and tobacco cessation treatment gaps; and (2) digital access screening and navigation.
  • Behavioral Enhancing Social Capital and Civic Engagement
    This community level intervention consists of a patient referral from a community health center to a community organization focused on building social capital and civic engagement to test the impact of connecting clinical and community resources explicitly for patients.

Primary outcome measures

  • Patients Screened for Colorectal Cancer [Time frame: change from baseline to end of intervention period, an average of 1 year]
  • Patients Screened for Breast Cancer [Time frame: change from baseline to end of intervention period, an average of 1 year]
  • Patients Screened for Cervical Cancer [Time frame: change from baseline to end of intervention period, an average of 1 year]
  • Patients Offered Pharmacotherapy for Smoking Cessation [Time frame: change from baseline to end of intervention period, an average of 1 year]
Secondary outcome measures (2)
  • Acceptability of the intervention [Time frame: Post intervention, 1 year follow up]
  • Feasibility of the intervention [Time frame: Post intervention, 1 year follow up]

Eligibility criteria

Study participants include community health center and community partner staff participating in surveys and interviews about the implementation of the intervention.

Inclusion criteria

  • Community health center staff or community partners
  • Age 18 or older

Exclusion criteria

  • Under 18

Patients will not be individually recruited for the study because the intervention is being offered as part of routine care.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Sequential
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 2 centers
  • Harvard TH Chan School of Public Health — Boston
  • Caring Health Center — Springfield

Identifiers

NCT: NCT07592793 · 241740 · U19CA291431

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗